Almac expands cold storage by 400%; New Gerresheimer chief aims for global growth;

> CMO Almac is betting on a surge in demand for cold storage as the pharmaceutical industry shifts focus towards temperature-sensitive biologics, boosting its capacity by 400 percent. Report

> New Gerresheimer CEO Uwe Roehrhoff wants the German firm to become the pharmaceutical and biopharmaceutical industry's "first choice" partner for high-tech packaging. Report

> India's Surya Pharmaceutical said it has started commercial production at its Jammu plant, which has the capacity to manufacture APIs and sterile products per U.S. FDA norms. Report

> Schott Pharmaceutical Packaging has boosted its U.S.-based ready-to-fill (RTF) syringe production line capabilities, counting on U.S. demand to grow by 10 percent per year. Report

> Indian Immunologicals, a subsidiary of National Dairy Development Board and the largest veterinary biological company in India, is setting up a new project for production of human and veterinary vaccines and veterinary formulations in Hyderabad. Report

> Saltigo has passed a manufacturing audit by the U.S. FDA as it prepares to produce an active ingredient to supply the U.S. market. Report

> Piramal Healthcare has agreed to buy BioSyntech in a deal worth $3.8 million, gaining access to BioSyntech's proprietary biotherapeutic thermogel technology. Report

Suggested Articles

A biotech that worked with a nutritional products maker on the API for its clinical-stage radiation drug, is buying all of the manufacturing know-how.

Merck KGaA is selling a manufacturing site and its Allergopharma allergy drug business as it focuses on newer meds.

In a first, the FDA and Indian oversight agencies worked together to block illegal drugs from entering the U.S.